Role of furosemide stress test as a novel assessment of tubular function in acute kidney injury / (رقم التسجيلة. 56658)
[ عرض عادي ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 03596cam a2200349 a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | EG-GiCUC |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250223031514.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 160528s2015 ua dh f m 000 0 eng d |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | EG-GiCUC |
| Language of cataloging | eng |
| Transcribing agency | EG-GiCUC |
| 041 0# - LANGUAGE CODE | |
| Language code of text/sound track or separate title | eng |
| 049 ## - LOCAL HOLDINGS (OCLC) | |
| Holding library | Deposite |
| 097 ## - Thesis Degree | |
| Thesis Level | M.Sc |
| 099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC) | |
| Classification number | Cai01.11.09.M.Sc.2015.Ma.R |
| 100 0# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Maha Mohammed Bayoumi Awad |
| 245 10 - TITLE STATEMENT | |
| Title | Role of furosemide stress test as a novel assessment of tubular function in acute kidney injury / |
| Statement of responsibility, etc. | Maha Mohammed Bayoumi Awad ; Supervised Hassan M. Khaled , Hamdy Mohamed Saber , Waleed Farouk Mahmoud |
| 246 15 - VARYING FORM OF TITLE | |
| Title proper/short title | استخدام عقار الفروسيميد بالجرعة الاجهادية لتحديد شدة الاصابة بالفشل الكلوى الحاد |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Place of publication, distribution, etc. | Cairo : |
| Name of publisher, distributor, etc. | Maha Mohammed Bayoumi Awad , |
| Date of publication, distribution, etc. | 2015 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 134 P. : |
| Other physical details | charts , facsimiles ; |
| Dimensions | 25cm |
| 502 ## - DISSERTATION NOTE | |
| Dissertation note | Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Critical Care Medicine |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Acute kidney injury is well recognized for its impact on the outcome of patients admitted to the intensive care unit (ICU) . The pursuit of improved biomarkers for the early diagnosis of AKI and its outcomes is an area of intense contemporary research; recent studies have demonstrated the utility of FST dose for predicting the severity of AKI, and possibility of administration as a treatment for AKIN I&II. Our study was conducted on eighty consecutive patients in the general ICU of Nasser institute hospital from July 2014 till July 2015. Forty of our patients received FST dose while the other forty patients received standard management of AKIN I, II. Any patient who develops acute kidney injury grade } - S according to (AKIN) will be subjected to: History taking including (co-morbidity drug intake), clinical examination., Kidney function tests (KFT) daily, estimated glomerular filtration rate GFR, Potassium, magnesium, sodium and phosphorus follow up daily for three days., Hemodynamic monitoring (heart rate HR, mean blood pressure BP, central venous pressure measurement CVP within six hours after inclusion, urine output per hour UOP / 6hour). In first 6 hours, there was a statistically significant increase in urine output in group I after 1st and 2nd hours (P value = 0.026, 0.008 respectively), as well as cumulative UOP over 6 hours (P value = 0.003), as compared to group II, Cut off point as regards UOP for detection of progress to AKINIII and dialysis was found to be 325ml in both group with sensitivity 86.7%, specificity 68% in group I and sensitivity 95%, 95%specificity in group II. There was a highly significant difference between the two groups concerning hypotension with 11 patients in group I vs. none in group II with P value = 0.001, and there was no significance difference between both groups concerning progression to AKIN III and dialysis with P value = 0.260,and there was no significance difference between the two groups concerning length of ICU stay with P value = 0.621, and according to mortality there was no significance difference between the two group with P value = 0.201.UOP in non progressed patients was higher than progressed patients in group I P value 0.001 |
| 530 ## - ADDITIONAL PHYSICAL FORM AVAILABLE NOTE | |
| Additional physical form available note | Issued also as CD |
| 653 #4 - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | AKI |
| 653 #4 - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | Dialysis |
| 653 #4 - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | Furosemide |
| 700 0# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hamdy Mohamed Saber , |
| Relator term | |
| 700 0# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hassan Mohamed Khaled , |
| Relator term | |
| 700 0# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Waleed Farouk Mahmoud , |
| Relator term | |
| 856 ## - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="http://172.23.153.220/th.pdf">http://172.23.153.220/th.pdf</a> |
| 905 ## - LOCAL DATA ELEMENT E, LDE (RLIN) | |
| Cataloger | Nazla |
| Reviser | Revisor |
| 905 ## - LOCAL DATA ELEMENT E, LDE (RLIN) | |
| Cataloger | Samia |
| Reviser | Cataloger |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | Dewey Decimal Classification |
| Koha item type | Thesis |
| Source of classification or shelving scheme | Not for loan | Home library | Current library | Date acquired | Full call number | Barcode | Date last seen | Koha item type | Copy number |
|---|---|---|---|---|---|---|---|---|---|
| Dewey Decimal Classification | المكتبة المركزبة الجديدة - جامعة القاهرة | قاعة الرسائل الجامعية - الدور الاول | 11.02.2024 | Cai01.11.09.M.Sc.2015.Ma.R | 01010110068992000 | 22.09.2023 | Thesis | ||
| Dewey Decimal Classification | المكتبة المركزبة الجديدة - جامعة القاهرة | مخـــزن الرســائل الجـــامعية - البدروم | 11.02.2024 | Cai01.11.09.M.Sc.2015.Ma.R | 01020110068992000 | 22.09.2023 | CD - Rom | 68992.CD |